Biote Reports First Quarter 2024 Financial Results

Go back to Biote Reports First Quarter 2024 Financial Results

biote Corp. (BTMD) PT Raised to $10 at Roth/MKM

May 8, 2024 7:11 AM EDT

Roth/MKM analyst George Kelly raised the price target on biote Corp. (NASDAQ: BTMD) to $10.00 (from $9.00) while maintaining a Buy rating.

The analyst comments "We like BTMD. 1Q24 results exceeded our estimates, procedure revenue stepped up sequentially and growth appears to have stabilized,... More